Literature DB >> 29750294

LncRNA uc.48+ is involved in the diabetic immune and inflammatory responses mediated by P2X7 receptor in RAW264.7 macrophages.

Hong Wu1, Fang Wen1, Mei Jiang1, Qiang Liu2, Yijun Nie1.   

Abstract

High glucose combined with high FFAs can contribute to the unfavorable development of type 2 diabetes mellitus (T2DM) and monocytes/macrophages are important in the occurrence and development of T2DM, which is regarded as a type of low‑grade inflammation. Although our previous study demonstrated that increased expression of P2X7 receptor (P2X7R) in peripheral blood monocytes may alter the innate immune system and that long non‑coding (lnc)RNA uc.48+ was involved in diabetic neuropathic pain, the involvement of uc.48+ mediated by the P2X7R in monocyte/macrophages during T2DM has not been reported. In the present study, the effectsof uc.48+ small interference RNA (siRNA) on factors, including the mRNA and protein expression of P2X7R, apoptosis and proliferation, levels of reactive oxygen species (ROS), cytokine levels, and expression of phosphorylated (p‑) extracellular signal‑regulated kinase (ERK)1/2, were examined in RAW264.7 macrophages following exposure to high glucose and high plasma free fatty acids (FFAs). After RAW264.7 cells were transfected with uc.48+ siRNA under high glucose conditions and FFAs treatment, the mRNA expression levels of uc.48+ and P2X7 receptor were detected by reverse transcription‑polymerase chain reaction. The protein mass of P2X7 receptor and ERK signaling pathway were assessed by western blotting. ROS and calcium concentrations, and culture supernatant cytokine content [tumor necrosis factor‑α, interleukin (IL)‑10, IL‑1β] were detected by fluorescent probes and ELISA respectively. Cell viability and apoptosis were determined by MTS test and flow cytometry, respectively. It was found that treatment of RAW264.7 cells with high glucose and FFAs, which exhibited increased expression of uc.48+, evoked P2X7R‑mediated immune and inflammatory responses through several means, including cytokine secretion, ROS formation, and activation of the ERK signaling pathway. The uc.48+ siRNA regulated these factors and thus influenced the course and outcome of the immune and inflammatory responses mediated by P2X7R.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29750294     DOI: 10.3892/ijmm.2018.3661

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

Review 1.  Long noncoding RNA (lncRNA): a target in neuropathic pain.

Authors:  Shaogen Wu; Jamie Bono; Yuan-Xiang Tao
Journal:  Expert Opin Ther Targets       Date:  2018-12-02       Impact factor: 6.902

Review 2.  New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors.

Authors:  Prabhakar Busa; Yaswanth Kuthati; Niancih Huang; Chih-Shung Wong
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

Review 3.  Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology.

Authors:  Revathy Nadhan; Ciro Isidoro; Yong Sang Song; Danny N Dhanasekaran
Journal:  Cells       Date:  2022-08-13       Impact factor: 7.666

4.  Downregulation of a Dorsal Root Ganglion-Specifically Enriched Long Noncoding RNA is Required for Neuropathic Pain by Negatively Regulating RALY-Triggered Ehmt2 Expression.

Authors:  Zhiqiang Pan; Shibin Du; Kun Wang; Xinying Guo; Qingxiang Mao; Xiaozhou Feng; Lina Huang; Shaogen Wu; Bailing Hou; Yun-Juan Chang; Tong Liu; Tong Chen; Hong Li; Thomas Bachmann; Alex Bekker; Huijuan Hu; Yuan-Xiang Tao
Journal:  Adv Sci (Weinh)       Date:  2021-05-14       Impact factor: 16.806

5.  Depression of lncRNA MINCR antagonizes LPS-evoked acute injury and inflammatory response via miR-146b-5p and the TRAF6-NFkB signaling.

Authors:  Wei Gao; Ying Zhang
Journal:  Mol Med       Date:  2021-10-03       Impact factor: 6.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.